Abstract:Background & Aims: <AbstractText Label="Background & Aims" NlmCategory="UNASSIGNED">Patients with acutely decompensated (AD) cirrhosis are immunocompromised and particularly susceptible to infections. This study investigated the immunomodulatory actions of albumin by which this protein may lower the incidence of infections.</AbstractText>Methods: <AbstractText Label="Methods" NlmCategory="UNASSIGNED">Blood immunophenotyping was performed in 11 patients with AD cirrhosis and 10 healthy volunteers (HV). Bulk and single-cell RNA sequencing (scRNA-seq) and flow cytometry were performed in peripheral blood mononuclear cells (PBMCs) from 20 patients with AD cirrhosis and 34 HV exposed to albumin. Albumin's effects on degranulation, phagocytosis, chemotaxis, and swarming of neutrophils from six patients with AD cirrhosis and nine HV were assessed by measuring myeloperoxidase enzymatic activity, the engulfment of fluorescent-labeled Escherichia coli and zymosan, and interactions of neutrophils with Candida albicans at single-cell resolution in microfluidic chambers, respectively. Whole blood RNA sequencing (RNA-seq) analyses were performed in 49 patients admitted for severe AD cirrhosis, of whom 30 received albumin during hospitalization.</AbstractText>Results: <AbstractText Label="Results" NlmCategory="UNASSIGNED">Compared with HV, patients with AD cirrhosis showed severe lymphopenia and defective neutrophil antimicrobial function. Bulk and scRNA-seq analyses revealed significantly (false discovery rate [FDR] <0.05) increased signatures related to B cells, myeloid cells, and CD4+ T cells in PBMCs incubated with albumin. Changes in the B cell population were confirmed by flow cytometry. Neutrophils exposed to albumin also exhibited augmented chemotactic and degranulation responses, enhanced phagocytosis, and increased pathogen-restrictive swarming. RNA-seq data analysis in patients who had received albumin revealed specific upregulation of signatures related to B cells and neutrophils together with transcriptional changes in CD4+ T cells (FDR <0.05).</AbstractText>Conclusions: <AbstractText Label="Conclusions" NlmCategory="UNASSIGNED">The finding that albumin promotes the transcriptional reprogramming and expansion of the B cell compartment and improves neutrophil antimicrobial functions indicates mechanisms that may lower the incidence of infections in patients with severe AD cirrhosis receiving albumin therapy.</AbstractText>Impact and implications: <AbstractText Label="Impact and implications" NlmCategory="UNASSIGNED">Patients with acutely decompensated cirrhosis receiving albumin as treatment have a lower incidence of infections. The reason for this protection is currently unknown, but the present study provides data that support the ability of albumin to boost the antimicrobial functions of immune cells in these patients. Moreover, these findings encourage the design of controlled clinical studies specifically aimed at investigating the effects of albumin administration on the immune system.</AbstractText>

Long‐term administration of human albumin improves survival in patients with cirrhosis and refractory ascites

Long-term therapy with intravenous human albumin increase survival in patients with decompensated cirrhosis and refractory ascites

Meta‐analysis: Efficacy and safety of albumin in the prevention and treatment of complications in patients with cirrhosis

Albumin in decompensated cirrhosis: new concepts and perspectives

Outpatient albumin infusions reduce hospitalizations and improve outcomes in decompensated cirrhosis: A real-world cohort study

Real-life experience of long-term albumin treatment for the management of ascites in patients with decompensated cirrhosis accross Italy

Albumin administration in patients with cirrhosis: Current role and novel perspectives

Albumin Reprograms the B cell Transcriptional Landscape and Improves Neutrophil Antimicrobial Function in Patients with Decompensated Cirrhosis.

Efficacy of albumin use in decompensated cirrhosis and real-world adoption in Australia

Albumin infusion reduces ascite occurrence in Child-Pugh B patients treated by Atezolizumab-Bevacizumab for advanced HCC

Role of albumin infusion in cirrhosis-associated complications

Albumin for Spontaneous Bacterial Peritonitis: Care Variation, Disparities and Outcomes

Beta-Blocker Use in Hospitalized Cirrhotic Patients with Ascites is Associated with A Lower Meld, Less Inflammation and an Improved Survival

[Efficiency of dialysis with albumin in the treatment of patients with advanced hepatic insufficiency: initial experience with the MARS system in Spain]

Timely Albumin Infusion May Improve Resource Utilization in Patients with Cirrhosis and Spontaneous Bacterial Peritonitis

Albumin in Advanced Liver Diseases: The Good and Bad of a Drug!

Impact of albumin infusion on prognosis in ICU patients with cirrhosis and AKI: insights from the MIMIC-IV database

Recent developments in the management of ascites in cirrhosis

The Effect of Albumin Administration in Critically Ill Patients: A Retrospective Single-Center Analysis

Association of Serum Albumin Levels and Long-Term Prognosis in Patients with Biopsy-Confirmed Nonalcoholic Fatty Liver Disease

The role of serum albumin in critical illness, predicting poor outcomes, and exploring the therapeutic potential of albumin supplementation